By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ezose Sciences and Hirosaki University in Japan today announced a glycomics research collaboration to identify new biomarkers for the prediction and monitoring of progress of prostate cancer and other urological cancers.

Under the terms of the deal, Hirosaki researchers will collect urine samples from well-characterized patients and control populations in Japan, and Ezose will analyze the samples using its GlycanMap platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."